We retrospectively evaluated 45 patients with ALS, 23 with CSM, 28 controls, and 10 with Parkinson’s disease (PD) who underwent analysis of CSF NSE levels. This evidence concerns the gene ENO2 and amyotrophic lateral sclerosis.